Literature DB >> 20153822

Functional analysis of H. sapiens DNA polymerase gamma spacer mutation W748S with and without common variant E1143G.

Eino J H Palin1, Annamari Lesonen, Carol L Farr, Liliya Euro, Anu Suomalainen, Laurie S Kaguni.   

Abstract

Mitochondrial DNA polymerase, POLG, is the sole DNA polymerase found in animal mitochondria. In humans, POLGalpha W748S in cis with an E1143G mutation has been linked to a new type of recessive ataxia, MIRAS, which is the most common inherited ataxia in Finland. We investigated the biochemical phenotypes of the W748S amino acid change, using recombinant human POLG. We measured processive and non-processive DNA polymerase activity, DNA binding affinity, enzyme processivity, and subunit interaction with recombinant POLGbeta. In addition, we studied the effects of the W748S and E1143G mutations in primary human cell cultures using retroviral transduction. Here, we examined cell viability, mitochondrial DNA copy number, and products of mitochondrial translation. Our results indicate that the W748S mutant POLGalpha does not exhibit a clear biochemical phenotype, making it indistinguishable from wild type POLGalpha and as such, fail to replicate previously published results. Furthermore, results from the cell models were concurrent with the findings from patients, and support our biochemical findings. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153822      PMCID: PMC2860656          DOI: 10.1016/j.bbadis.2010.02.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  34 in total

1.  Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia.

Authors:  Eleonora Lamantea; Valeria Tiranti; Andreina Bordoni; Antonio Toscano; Francesco Bono; Serena Servidei; Alex Papadimitriou; Hans Spelbrink; Laura Silvestri; Giorgio Casari; Giacomo P Comi; Massimo Zeviani
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

Review 2.  DNA polymerase gamma, the mitochondrial replicase.

Authors:  Laurie S Kaguni
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

3.  POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion.

Authors:  Robert K Naviaux; Khue V Nguyen
Journal:  Ann Neurol       Date:  2004-05       Impact factor: 10.422

4.  Reconstitution of a minimal mtDNA replisome in vitro.

Authors:  Jenny A Korhonen; Xuan Hoi Pham; Mina Pellegrini; Maria Falkenberg
Journal:  EMBO J       Date:  2004-05-27       Impact factor: 11.598

5.  Structural basis for the dual coding potential of 8-oxoguanosine by a high-fidelity DNA polymerase.

Authors:  Luis G Brieba; Brandt F Eichman; Robert J Kokoska; Sylvie Doublié; Tom A Kunkel; Tom Ellenberger
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

6.  Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.

Authors:  Petri Luoma; Atle Melberg; Juha O Rinne; Jyrki A Kaukonen; Nina N Nupponen; Richard M Chalmers; Anders Oldfors; Ilkka Rautakorpi; Leena Peltonen; Kari Majamaa; Hannu Somer; Anu Suomalainen
Journal:  Lancet       Date:  2004 Sep 4-10       Impact factor: 79.321

7.  Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions.

Authors:  G Van Goethem; B Dermaut; A Löfgren; J J Martin; C Van Broeckhoven
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

8.  Adult-onset autosomal recessive ataxia with thalamic lesions in a Finnish family.

Authors:  M Rantamäki; R Krahe; A Paetau; B Cormand; I Mononen; B Udd
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

9.  Structural insight into processive human mitochondrial DNA synthesis and disease-related polymerase mutations.

Authors:  Young-Sam Lee; W Dexter Kennedy; Y Whitney Yin
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

10.  Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia.

Authors:  G Van Goethem; J J Martin; B Dermaut; A Löfgren; A Wibail; D Ververken; P Tack; I Dehaene; M Van Zandijcke; M Moonen; C Ceuterick; P De Jonghe; C Van Broeckhoven
Journal:  Neuromuscul Disord       Date:  2003-02       Impact factor: 4.296

View more
  5 in total

1.  Mapping 136 pathogenic mutations into functional modules in human DNA polymerase γ establishes predictive genotype-phenotype correlations for the complete spectrum of POLG syndromes.

Authors:  Gregory A Farnum; Anssi Nurminen; Laurie S Kaguni
Journal:  Biochim Biophys Acta       Date:  2014-02-07

Review 2.  Clustering of Alpers disease mutations and catalytic defects in biochemical variants reveal new features of molecular mechanism of the human mitochondrial replicase, Pol γ.

Authors:  Liliya Euro; Gregory A Farnum; Eino Palin; Anu Suomalainen; Laurie S Kaguni
Journal:  Nucleic Acids Res       Date:  2011-08-08       Impact factor: 16.971

3.  Yeast model analysis of novel polymerase gamma variants found in patients with autosomal recessive mitochondrial disease.

Authors:  Magdalena Kaliszewska; Jakub Kruszewski; Biruta Kierdaszuk; Anna Kostera-Pruszczyk; Monika Nojszewska; Anna Łusakowska; Joel Vizueta; Dorota Sabat; Dorota Lutyk; Michał Lower; Dorota Piekutowska-Abramczuk; Aneta Kaniak-Golik; Ewa Pronicka; Anna Kamińska; Ewa Bartnik; Paweł Golik; Katarzyna Tońska
Journal:  Hum Genet       Date:  2015-06-16       Impact factor: 4.132

4.  Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae.

Authors:  Enrico Baruffini; Jessica Ferrari; Cristina Dallabona; Claudia Donnini; Tiziana Lodi
Journal:  Mitochondrion       Date:  2014-11-18       Impact factor: 4.160

5.  Pathogenicity in POLG syndromes: DNA polymerase gamma pathogenicity prediction server and database.

Authors:  Anssi Nurminen; Gregory A Farnum; Laurie S Kaguni
Journal:  BBA Clin       Date:  2017-04-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.